Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Claus

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|July 30, 2010
Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locusLukas P Frenzel, Rainer Claus, Nadine Plume, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2021
Alterations of circulating lymphocyte subsets in patients with colorectal carcinomaJohanna Waidhauser, Pia Nerlinger, Tim Tobias Arndt, et al.
Plos One|May 11, 2010
HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumorsKalpana Ghoshal, Tasneem Motiwala, Rainer Claus, et al.
Cancer Reports (Hoboken, N.J.)|November 11, 2023
Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT)Sebastian Sommer, Maximilian Schmutz, Tina Schaller, et al.
International Journal of Cancer|February 24, 2015
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemiaConstance Baer, Christopher C Oakes, Amy S Ruppert, et al.
Cancer Research|December 17, 2010
CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cellsChristoph Dürr, Dietmar Pfeifer, Rainer Claus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
CCK<sub>2</sub> Receptor Ligand [<sup>68</sup>Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [<sup>68</sup>Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung CancerOliver Viering, Nadine Holzleitner, Rainer Claus, et al.
Plos One|June 25, 2014
Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changesAlexander Krohn, Theresa Ahrens, Arzu Yalcin, et al.
Oncoimmunology|July 7, 2017
Tumor-priming converts NK cells to memory-like NK cellsMarina Pal, Lisa Schwab, Anastasiya Yermakova, et al.
Leukemia Research|June 1, 2016
Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesisChristoph Niemöller, Nathalie Renz, Sabine Bleul, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|July 30, 2010
Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locusLukas P Frenzel, Rainer Claus, Nadine Plume, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2021
Alterations of circulating lymphocyte subsets in patients with colorectal carcinomaJohanna Waidhauser, Pia Nerlinger, Tim Tobias Arndt, et al.
Plos One|May 11, 2010
HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumorsKalpana Ghoshal, Tasneem Motiwala, Rainer Claus, et al.
Cancer Reports (Hoboken, N.J.)|November 11, 2023
Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT)Sebastian Sommer, Maximilian Schmutz, Tina Schaller, et al.
International Journal of Cancer|February 24, 2015
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemiaConstance Baer, Christopher C Oakes, Amy S Ruppert, et al.
Cancer Research|December 17, 2010
CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cellsChristoph Dürr, Dietmar Pfeifer, Rainer Claus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
CCK<sub>2</sub> Receptor Ligand [<sup>68</sup>Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [<sup>68</sup>Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung CancerOliver Viering, Nadine Holzleitner, Rainer Claus, et al.
Plos One|June 25, 2014
Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changesAlexander Krohn, Theresa Ahrens, Arzu Yalcin, et al.
Oncoimmunology|July 7, 2017
Tumor-priming converts NK cells to memory-like NK cellsMarina Pal, Lisa Schwab, Anastasiya Yermakova, et al.
Leukemia Research|June 1, 2016
Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesisChristoph Niemöller, Nathalie Renz, Sabine Bleul, et al.
Pageof 14